M o rtality in Adults With and Wi t h o u t Diabetes in a National Cohort of the U.S. Population, 1971-1993 O R I G I N A L A R T I C L E
O B J E C T I V E -To examine 22-year mortality , causes of death, life expectancy, and survival in a national sample of diabetic and nondiabetic adults according to age, sex, and r a c e .
RESEARCH DESIGN AND METHODS
-A re p resentative national cohort of 14,374 adults aged 25-74 years was identified in [1971] [1972] [1973] [1974] [1975] in the First National Health and Nutrition Examination Survey (NHANES I). Diabetes was ascertained by medical history interv i e w. The cohort was followed for mortality through 1992-1993, with verification of vital status for 96.2% (n = 13,830). Causes of death were determined from death cert i fic a t e s .
R E S U LT S -Diabetic subjects comprised 5.1% of the cohort and accounted for 10.6% of the deaths. Mortality for diabetic subjects increased from 12.4 per 1,000 person-years for those aged 25-44 years at baseline to 89.7 per 1,000 person-years for those aged 65-74 years. The age-adjusted mortality rate was 57% higher for diabetic men than for diabetic women; the rate was 27% higher for diabetic non-Hispanic blacks than for diabetic non-Hispanic whites. Mortality rates were highest for insulin-treated subjects and for those with 15 years' duration of diabetes. Diabetes was listed on the death cert i ficate as the underlying cause of death for only 7.7% of diabetic men and 13.4% of diabetic women. Considering multiple causes of death, h e a rt disease was listed the most frequently and was present on 69.5% of death cert i ficates of people with diabetes. Death rates were higher for diabetic than for nondiabetic subjects in all age, sex, and race groups. The relative risk of death (diabetic versus nondiabetic subjects) declined with age from a value of 3.6 for those aged 25-44 years at baseline to 1.5 for those aged 65-74 years. The relative risk was elevated in diabetic subjects for all major causes of death except malignant neoplasms. Survival of diabetic subjects was lower than that of nondiabetic subjects in all age, sex, and race groups. Median life expectancy was 8 years lower for diabetic adults aged 55-64 years and 4 years lower for those aged 65-74 years.
C O N C L U S I O N S -In this re p resentative national sample of adults, mortality rates were higher for diabetic men than for diabetic women and for diabetic blacks than for diabetic whites. The study confirms the substantially higher risk of death, lower survival, and lower life expectancy of diabetic adults compared with nondiabetic adults.
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Gu, Cowie, and Harris follow-up were calculated for each subject as the diff e rence between the last known year alive and the year of baseline examination. The number of deaths was divided by the summed person-years of follow-up to produce the mortality rate. Data were computed for non-Hispanic whites and blacks, but the number of Hispanics was insufficient to allow separate analysis of this ethnic gro u p .
A g e -s t a n d a rdized rates were computed by the direct method, using the age distribution of the 1980 U.S. population. Life expectancy and survival times were estimated by the Kaplan-Meier product-limit method. Cox p ro p o rtional hazard analysis was used to test statistical significance of age-specific mort a lity ratios computed using the person-year denominator and to compute relative risks adjusted for multiple risk factors.
R E S U LT S
Mortality rates in adults with diabetes People with diabetes comprised 5.1% of the 13,830 subjects who were followed for m o rtality and accounted for 10.6% of the deaths. Through the 1992-1993 followup, 33.7% of those with diabetes who were aged 25-54 years at baseline and 82.9% of those aged 55-74 years had died, comp a red with 10.2 and 64.4% of people without diabetes, re s p e c t i v e l y.
F i g u re 1 shows 22-year mortality rates for people with diabetes by age, sex, and race. The rates increased with age for both sexes. Rates were higher for men than for women in each age-group, and the ratio of the age-standardized mortality rate for diabetic men versus diabetic women was 1.7 for non-Hispanic whites and 1.5 for nonHispanic blacks. Mortality was somewhat higher for blacks compared with whites: for men, the age-standardized rate ratio was 1.2; for women, the rate ratio was 1.4.
The effect of baseline measures of diabetes severity on mortality is shown in Fig.  2 . The age-adjusted mortality rate was highest for insulin users and lowest for those treated with diet alone. Those with 15 years' duration of diabetes at baseline had higher mortality than those with 5 or 5-14 years' duration.
M o rtality rates for diabetic subjects were recomputed excluding those with pro b a b l e type 1 diabetes (based on diagnosis of diabetes at age 30 years, n = 49). Resulting rates were virtually the same as those computed using the full diabetic population.
Mortality rates in people with diabetes versus people without diabetes Individuals with diabetes had higher death rates than nondiabetic individuals in all age, sex, and race groups (Table 1 ). 
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Although mortality rates increased with age, the risk of death for diabetic adults c o m p a red with nondiabetic adults declined markedly with increasing age at baseline (Fig. 3) . The ratio of the mortality rates for diabetic versus nondiabetic subjects was highest for those aged 25-44 years, with a value of 3.6, and declined to 2.2 for those aged 45-64 years and to 1.5 for those aged 65-74 years. This decrease with age was found for both men and women (Fig. 3) . The relative risk was higher for men than women among those aged 25-44 years at baseline, but was higher for women than men among those aged 45-64 and 65-74 years, when most of the deaths occurre d .
The diabetic versus nondiabetic risk of death was similar for non-Hispanic whites and non-Hispanic blacks (Table 1) . For example, the ratio of the mortality rate for diabetic men compared with nondiabetic men aged 45-64 years was 2.0 for non-Hispanic whites and 2.3 for non-Hispanic blacks; at age 65-74 years, the ratios were 1.4 and 1.5, re s p e c t i v e l y. For women, the ratios at age 45-64 years were 2.5 for whites and 2.2 for blacks, and at age 65-74 years, the ratios were 1.7 and 1.4, re s p e c t i v e l y.
Individuals without a medical history of diabetes at baseline who had diabetes diagnosed during the follow-up period w e re identified from interview and death c e rt i ficate data. When these people were excluded from analysis, the death rates for nondiabetic subjects declined an average of 3%, and the relative mortality risks for diabetic versus nondiabetic subjects incre a s e d by this amount.
Risk factors for mortality diff e re d between people with and without diabetes (data not shown). Those with diabetes were o l d e r, were more often black, and had fewer years of education. Diabetic subjects had higher levels of risk factors for card i ovascular disease and more frequently had a medical history of cardiovascular disease. Mean BMI was higher, and amount of re p o rted physical activity was lower, for diabetic adults compared with nondiabetic adults. The relative risk of death for diabetic versus nondiabetic adults declined slightly when the effects of these variables w e re adjusted for, using a Cox pro p o rt i o n a l h a z a rds model, compared with a model 
Causes of death
Causes of death listed on the death cert i ficates of diabetic men and women are shown in Table 2 . There was significant underrep o rting of diabetes. Only 36.0% of diabetic men and 47.2% of diabetic women had diabetes (any 250 code) listed on their death c e rt i ficate, and diabetes was the underlying cause in only 7.7 and 13.4%, re s p e c t i v e l y. H e a rt disease was the most frequently listed cause of death, present on 69.5% of diabetes death cert i ficates (men and women combined), with ischemic heart disease listed on 45.6%. Renal diseases (including diabetic renal disease, ICD-9 250.3) were found in 12.0%. There were no substantial diff e re n c e s between diabetic men and women in the p e rcent of deaths in which specific conditions were listed on the death cert i fic a t e , except for diabetes and cere b ro v a s c u l a r disease. Compared with people without diabetes, ischemic heart disease and cere b rovascular disease were more frequently listed for people with diabetes, and malignant neoplasms were less frequently listed. The pre sence of diabetes on the death cert i ficates of people without known diabetes at baseline ( Table 2 ) occurred in those who were diagnosed during the follow-up period. Death rates for the most common causes of death, using multiple-cause data, a re presented in Table 3 . Age-adjusted mortality rates were higher for diabetic adults c o m p a red with nondiabetic adults for each of the major causes of death except cancer, for which the mortality rates were similar for people with and without diabetes. The m o rtality risk ratios were higher for diabetic women than diabetic men for many of the individual causes of death.
Survival and life expectancy F i g u re 4 shows Kaplan-Meier surv i v a l c u rves for subjects followed for up to 22 years, by age at baseline. The fig u re shows that diabetic men and women experienced p o o rer survival than nondiabetic adults in all age-groups and throughout the followup. For example, among people aged 45-64 years at baseline, 65% of those without diabetes were still alive at the end of follow-up, compared with 37% of people with diabetes. Diabetic survival was lower for both non-Hispanic whites and nonHispanic blacks.
The median life expectancy for diabetic subjects aged 55-64 at baseline was 10 years for men and 17 years for women; at age 65-74 years, the values were 8 and 11 years, re s p e c t i v e l y. Compared with nondiabetic subjects, life expectancy was 8 years shorter for adults with diabetes at age 55-64 years and 4 years shorter at age 65-74 years. Median life expectancy could not be computed for subjects aged 5 5 years because 50% of the cohort had died by the end of follow-up. Table 4 shows the percentage of people who were alive after 5, 10, 15, and 20 years of followup. As years of follow-up or age at baseline i n c reased, the survival of those with diabetes became less favorable relative to those without diabetes. Survival was poorer for men than women and for blacks than whites in all age-groups and at all years of f o l l o w -u p .
C O N C L U S I O N S -Our results are
consistent with a number of cohort and community-based studies that show that m o rtality is greater in diabetic subjects than in nondiabetic subjects (1-9). Overall ageadjusted mortality in diabetic adults is a p p roximately twice that in people without diabetes (10), but the magnitude of the diff e rence has varied somewhat among diff e rent populations. We found large decre a s e s in relative risk of death with increasing age in the NHANES I cohort (Fig. 3) , and such d i ff e rences with age may explain some of the discrepancy among published studies. The decline with age may be due to a more s e v e re effect of diabetes and its complications on mortality in younger people. It may also be due to an increase with age in l i f e -t h reatening diseases among those without diabetes, such that their mortality experience becomes more like that of older See Table 2 for ICD-9 codes. Rates are computed based on multiple cause data, whereby a death was included in a specific cause-of-death category if that cause was listed on the death certificate.
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people with diabetes. Even though the re lative mortality risk became smaller with i n c reasing age in NHANES I, it was still substantial at older ages (relative risk of 1.4-1.7 at age 65-74 years). Among adults with diabetes in the NHANES I cohort, women experienced lower mortality than men, and non-Hispanic whites experienced lower mort a l i t y than non-Hispanic blacks. These pattern s o c c u rred in the nondiabetic group also, with the result that the relative risk for mortality in diabetic versus nondiabetic adults was elevated for all groups-men, women, non-Hispanic whites, and non-Hispanic blacks. The relative risk ranged from 2.0 to 2.5 at age 45-64 years and from 1.4 to 1.7 at age 65-74 years. There appears to be no race/ethnic diff e rence in relative risk. Howe v e r, diabetic women had higher re l a t i v e risks than men at age 45-64 years and age 65-74 years for all causes of death combined. They had higher relative risks for many individual causes of death also. Other studies have found that the relative risk is g reater for diabetic women than for diabetic men, although the magnitude of the diff e rence has varied among studies (5,13-16).
Causes of death were similar for diabetic men and women, except for stroke, which was more frequently listed on the death cert i ficates of women. Heart diseases were involved in the majority of deaths (69.5%) of people with diabetes, and it thus appears that effective prevention and treatment of h e a rt disease would have the greatest impact on reducing the diabetes mortality rate. H o w e v e r, the mortality diff e rence between diabetic and nondiabetic subjects in our study and in other studies is not fully explained by diff e rences in heart disease risk factors, and a twofold excess risk re m a i n s that can be attributed to diabetes.
Many previous studies have shown that diabetes and other conditions are u n d e rre p o rted as causes of death on death c e rt i ficates. The NHANES I data pro v i d e evidence of underre p o rting of diabetes, and for this reason, we analyzed multiple causes of death. Our study could not precisely diff e rentiate the types of diabetes, but the adult age of the NHANES I cohort and the high pro p o rtion of type 2 diabetes in the U.S. diabetic population (17, 18) indicate that the results re flect mortality in type 2 patients. When we excluded the small g roup of diabetic subjects with age at diagnosis 30 years (an approximation of type 1 diabetes), the mortality rates were virt ually unchanged. Our data also do not per-F i g u re 4-Kaplan-Meier survival curves for a r e p resentative national sample of diabetic and nondiabetic adults in NHANES I who were followed for mortality from 1971-1975 through 1992-1993, accor ding to sex and age at baseline. a national cohort, 1971-1993 mit identification of people with undiagnosed diabetes because neither a fasting glucose value nor an oral glucose tolerance test were obtained in NHANES I. Other studies have shown that mortality rates for individuals with undiagnosed diabetes are a p p roximately equal to the rates for patients with diagnosed diabetes (19, 20) . Many of those with undiagnosed diabetes at the baseline study of NHANES I would have been diagnosed during the 22-year follow-up period. When these newly diagnosed individuals were excluded from the baseline nondiabetic group, the mort a l i t y rates for the nondiabetic group declined 3%, and the age-adjusted relative risk i n c reased by this amount.
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In summary, this study confirms, in a re p resentative national sample of adults, the higher risk of death, lower survival, and lower life expectancy of diabetic subjects c o m p a red with nondiabetic subjects. The m o rtality risk conferred by diabetes was similar among all race-sex gro u p s . Although the relative risk of death was elevated for many conditions, the majority of deaths involved heart disease, part i c u l a r l y ischemic heart disease. Greater eff o rts in diabetes management and treatment of h e a rt disease risk factors should help to d e c rease the mortality rate and increase the life expectancy for people with diabetes.
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